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Background:  Tetralogy of Fallot (TOF) is one of the most common congenital heart diseases (CHD). Over 90% of all patients with CHD, 
including those with TOF, are expected to live to adulthood. Chronic pulmonary insufficiency in TOF leads to right ventricular (RV) dilation 
and is associated with increased arrhythmias and death. The timing of pulmonary valve replacement in adults with TOF is largely based 
on RV size. RV end-diastolic volume indexed (RVEDVI) to body surface area (BSA) > 150mL/m2 has been suggested as a threshold for 
pulmonary valve replacement and reversible RV dilation. We hypothesized a weight-based index would underestimate RV volume in obese 
patients compared to normal weight patients.
methods:  A single institution retrospective review was performed of all patients with diagnosis of TOF or TOF/pulmonary atresia who 
underwent cardiac magnetic resonance imaging (MRI) from January 1, 2001 through September 30, 2014. Patients were excluded for 
age < 18 years or if biometric data were not available. Using each subject’s height as a constant, BSA was calculated by Dubois method 
at ideal body mass index (BMI), defined as 24 kg/m2, and obese BMI, defined as 30 kg/m2. The calculated BSA values were then used to 
determine RVEDVI for ideal and obese weights. Comparisons were made using paired t-test. P-value <0.05 was considered significant.
results:  36 patients (55% male) met inclusion criteria. The mean age of the cohort was 27.7±9.3 years, height was 166.7±11.3 cm and 
weight was 72.5±19.7 kg. The mean difference in RVEDVI between the ideal weight and obese groups using calculated BSA was 11.5 
mL/m2 (p<0.001). The RVEDVI was 10% less in the obese group. 8 patients were actually obese at the time of MRI. In this subgroup, 
the mean RVEDVI was 25.8 mL/m2 less (129.4 mL/m2 vs 155.2 mL/m2) when using actual BSA from the subjects’ true, obese weight 
compared to the RVEDVI based on calculated ideal weight (p<0.002). The RVEDI was 20% less for obese weight compared to normal 
weight.
Conclusion:  Indexing RV volume to a weight-dependent measure significantly underestimates the degree of RV dilation in adults with 
TOF. This underestimation delays intervention and may contribute to increased morbidity and mortality.
